Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Depression × Ultraviolet Therapy × Clear all

Phase

Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Parasomnias 1 Fatigue 1 Depression 1 Anxiety Disorders 1

Interventions

Oxygen 2 Melatonin 2 Ultraviolet Therapy 1 Surveys and Questionnaires 1 Saline Solution 1 Referral and Consultation 1 Psychotherapy, Group 1 Mindfulness-Based Stress Reduction 1 Methylphenidate 1 Ketamine 1 Fatty Acids, Omega-3 1 Desvenlafaxine Succinate 1 Cognitive Behavioral Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01193530 2019-03-26

The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Terminated

12 enrolled 3 charts

Anxiety Disorders, Depression, Fatigue, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡